Corpay, Inc. reported strong second quarter 2026 growth, with revenues increasing 21% to $1,338.8 million versus 2025. Organic revenue growth was 10%. However, net income attributable to Corpay declined 13% to $248.3 million and diluted EPS fell 7% to $3.70, reflecting a $100 million charge for a preliminary settlement with the FTC’s Bureau of Consumer Protection.
On a non-GAAP basis, performance was much stronger: adjusted EBITDA rose 24% to $767.2 million (57.3% margin), adjusted net income increased 27% to $464.4 million, and adjusted diluted EPS grew 36% to $7.00. Corporate Payments delivered 42% revenue growth, and the company ended the quarter with 2.55x leverage, an upsized $3.7 billion revolving credit facility, and repurchases of 1 million shares for $321 million.
Reflecting this performance, Corpay raised its 2026 outlook, now guiding to total revenues of $5.290–$5.330 billion, net income of $1.285–$1.325 billion, and adjusted diluted EPS of $27.15–$27.55, 28% growth at the midpoint. For third quarter 2026, revenue is expected to be about $1.355 billion at the midpoint, with adjusted diluted EPS of $7.15.
Netto Armando Lins reported acquisition or exercise transactions in this Form 4 filing.
CORPAY, INC. granted Group President Brazil & US Vehicle Payments Armando Lins Netto three tranches of performance-based restricted stock units totaling 28,213 units. Each unit represents a contingent right to one share of CPAY common stock. The tranches cover 9,405, 9,404 and 9,404 units that may be earned only if the CPAY share price equals or exceeds $425.00, $450.00 and $475.00, respectively, on five separate trading days before August 31, 2028, and remain subject to the company’s equity compensation plan and award agreement terms.
Clarke Ronald reported acquisition or exercise transactions in this Form 4 filing.
Corpay, Inc. reported that CEO and Chairman Ronald Clarke received grants of three tranches of 100,000 performance-based restricted stock units, each settled in common stock. Each tranche is earned only if CPAY’s closing price equals or exceeds $425, $450, or $475 on five separate trading days before August 31, 2028, with vesting of earned units subject to the company’s equity compensation plan and related award agreements.
Corpay, Inc. reports that its Compensation Committee approved special grants of performance-based restricted stock units (PSUs) under the Amended and Restated 2010 Equity Compensation Plan to Ronald F. Clarke and Armando L. Netto, effective July 22, 2026. Clarke received 300,000 PSUs and Netto received 28,213 PSUs, which are intended to align their compensation with shareholder stock price interests and support retention over the applicable period.
The PSUs have a performance period running from the Grant Date through August 31, 2028. They are earned in tranches upon achievement of stock price hurdles: 100,000 PSUs for Clarke and 9,405 for Netto if the closing price equals or exceeds $425.00 on five separate trading days during the period; additional 100,000 and 9,404 PSUs at $450.00; and the remaining 100,000 and 9,404 PSUs at $475.00, with vesting of earned PSUs further subject to the Plan and related award agreements.
Corpay CFO Peter Walker reported compensation-related equity activity on July 15, 2026. The company withheld a total of 1,660 shares of common stock at $356.16 per share to cover tax liabilities on vesting awards. He also received 568 vested performance-based shares and a new 938-share performance-based restricted stock award that will vest in thirds through 2028, subject to continued employment; no open-market trades were reported.
Corpay, Inc. executive Armando Lins reported an exercise-and-sell transaction in company stock. On June 15, 2026, he exercised employee stock options to acquire a total of 70,476 shares of Corpay common stock and, on the same date, completed an open-market sale of 70,476 common shares at an average price of $352.1308 per share.
Following these transactions, Lins holds 11,274 Corpay common shares directly. The derivative summary in this filing shows no remaining employee stock options, indicating that the reported option positions were fully exercised.
Corpay, Inc. director Steven T. Stull reported an open-market sale of 1,000 shares of Common Stock at $360.78 per share on June 2, 2026. After this transaction, he directly holds 28,241 Corpay shares. The filing also notes 6,247 shares held indirectly "by Funds," over which he has shared voting power through Advantage Capital Financial Company, LLC and related entities, while disclaiming beneficial ownership beyond his pecuniary interest.
CPAY notice of proposed sale: an officer reported multiple dispositions of Common Stock and listed several option exercises under a registered plan.
Armando Netto reported sales of 4,560, 2,694, 14,089, and 418 shares on 05/27/2026–06/11/2026. The filing also shows planned option exercises and cash exercises dated 06/15/2026 totaling individual lots of 20,000, 513, 18,352, 18,352, and 13,259 shares.
CORPAY, INC. Group President Armando Lins Netto sold 4,560 shares of Common Stock in an open-market transaction at $351.6025 per share. After this sale, he directly holds 11,274 shares, so the transaction reduces but does not eliminate his personal equity stake.
Armando Netto reported sale of Common Stock under Rule 144. The filing lists three dispositions on 05/27/2026, 05/28/2026, and 05/29/2026 showing 418, 14,089, and 2,694 shares sold respectively, with proceeds recorded for each sale. The filing also lists several restricted stock vesting entries dated in January and February 2025 tied to services rendered.